MindBio Therapeutics is a clinical stage drug development company that is pioneering psychedelic microdosing. With its first candidate drug LSD currently in Phase 1 clinical trials microdosing LSD in 80 healthy participants. In a world first clinical trial of its kind, participants are prescribed the microdoses of LSD to take home with them after receiving a battery of psychological and biometric baseline tests in the laborato...
MindBio Therapeutics is a clinical stage drug development company that is pioneering psychedelic microdosing. With its first candidate drug LSD currently in Phase 1 clinical trials microdosing LSD in 80 healthy participants. In a world first clinical trial of its kind, participants are prescribed the microdoses of LSD to take home with them after receiving a battery of psychological and biometric baseline tests in the laboratory. Phase 2 clinical trials microdosing LSD have just been approved in late stage cancer patients experiencing existential distress, anxiety and depression.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.